Ryan Smith Westberry

Title: Innovations of Ryan Smith Westberry

Introduction

Ryan Smith Westberry is an accomplished inventor based in Westminster, Colorado. He has made significant contributions to the field of nucleic acid amplification through his innovative patent. His work focuses on enhancing the specificity and sensitivity of amplification reaction mixtures, which is crucial for various applications in molecular biology.

Latest Patents

Westberry holds a patent for "dUTP-based compositions for reducing primer-aggregate formations during nucleic acid amplification." This invention provides methods and compositions that reduce the formation of primer-aggregates during amplification reactions. The reaction mixes include deoxynucleotide triphosphates (dNTPs), where a portion of the dNTPs is replaced with an unconventional nucleotide, such as dUTP. The concentrations of these unconventional nucleotides typically range from 10% to 50% of the concentration of one of the standard dNTPs. In some compositions, dUTP replaces from about 10% to about 50% of the dTTP in the dNTP mix.

Career Highlights

Westberry is currently associated with Qiagen North American Holdings, Inc., a leading company in the field of molecular diagnostics and research. His work at Qiagen has allowed him to further develop his innovative ideas and contribute to advancements in nucleic acid technologies.

Collaborations

Throughout his career, Westberry has collaborated with notable colleagues, including Lars-Erik Peters and Jessica Jaclyn Greenlee. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Ryan Smith Westberry is a notable inventor whose work in nucleic acid amplification has the potential to impact various scientific and medical fields. His innovative patent and contributions to Qiagen North American Holdings, Inc. highlight his commitment to advancing technology in molecular biology.